-
Africa: Preventing TB - a Big Drug Price Cut Paves the Way for Global Scale-Up
The Conversation Africa, 13 January 2020
Lengthy negotiations ended in good news recently when the price of rifapentine, a lifesaving antibiotic, was marked down by 66% by its manufacturer Sanofi. When combined with… Read more »
Drug Price Cut Paves Way in Global Fight Against Tuberculosis
The price of rifapentine, a lifesaving antibiotic that can prevent tuberculosis, was marked down by 66% by its manufacturer Sanofi, an announcement Gavin Churchyard for The Conversation Africa describes as good news. Talks to lower the price from U.S.$45 to U.S.$15 for a three-month course took more than a year to complete with an announcemnt eventually made during the Union World Conference on Lung Health in October 2019.
-
Africa: Drug Price Drop to Bolster African Countries' Fight Against TB
allAfrica, 12 November 2019
A French pharmaceutical giant has slashed the price of a critically important antibiotic used to prevent tuberculosis, giving new hope of beating the disease to millions of people… Read more »
InFocus
-
The cost of the drug, rifapentine, will be cut from U.S.$45 to $15 dollars for a recommended three-month course of treatment in 100 nations - including 48 in Africa - where TB is a ... Read more »
-
People with drug-resistant tuberculosis continue to be deprived of the best-possible treatment in part because of high drug prices, according to Doctors Without Borders. Read more »
-
"TB remains the world's deadliest infectious killer. Each day, nearly 4,500 people lose their lives to TB and close to 30,000 people fall ill with this preventable and curable ... Read more »
